Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AKEBIA THERAPEUTICS, INC.

(AKBA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Akebia Therapeutics : Announces September 2021 Investor Conference Schedule

09/01/2021 | 08:01am EDT

CAMBRIDGE, Mass., Sept. 1, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, and David A. Spellman, Chief Financial Officer, will participate in the following schedule of investor conferences:

  •   Morgan Stanley 19th Annual Global Healthcare Conference
    Virtual fireside chat at 2:45 p.m. ET on September 9

  • H.C. Wainwright 23rd Annual Global Investment Conference
    On-demand presentation available at 7:00 a.m. ET on September 13

  • Cantor Fitzgerald Virtual Global Healthcare Conference 2021
    Virtual presentation at 2:00 p.m. ET on September 27

Where applicable, live webcasts of Akebia's fireside chats and presentations will be made available on the Investors section of the Company's website at https://ir.akebia.com .

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Kristen K. Sheppard, Esq.
ir@akebia.com

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-september-2021-investor-conference-schedule-301366758.html

SOURCE Akebia Therapeutics


ę PRNewswire 2021
All news about AKEBIA THERAPEUTICS, INC.
10/19AKEBIA THERAPEUTICS : Announces Vadadustat Efficacy and Safety Data to be Presented at Ame..
AQ
10/14IMMUNIC : Hires Patrick Walsh as Chief Business Officer
MT
10/14PRESS RELEASE : Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer
DJ
10/11Health Care Stocks Sliding in Late Monday Trading
MT
10/11Health Care Stocks Drifting Monday as Biotechs Climb
MT
10/01AKEBIA THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
09/28AKEBIA THERAPEUTICS, INC. : Other Events (form 8-K)
AQ
09/09AKEBIA THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f..
AQ
09/02AKEBIA THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
09/01AKEBIA THERAPEUTICS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR
More news
Analyst Recommendations on AKEBIA THERAPEUTICS, INC.
More recommendations